The Tirzepatide groups consistently showed shorter mean follow-up periods (390.09395.18 days), which corresponds to its more recent market introduction compared to the other medications studied (Supplementary Table 1)
Such issues create potential problems in the reliability of the compounds to effectively treat patients
But it can be psychologically frustrating, especially if you are watching the scale daily
This is one of the reasons published Tirzepatide research is typically discussed not only in terms of efficacy, but also in terms of tolerability during escalation , GI event burden and the balance between metabolic benefit and dropout risk
Desai A, Khataniar H, Hashash JG, Farraye FA, Regueiro M, Kochhar GS
and, Additional risks to watch out for when taking Ozempic include thyroid C-cell tumors, other thyroid issues, pancreatitis, diabetic retinopathy, acute kidney injury, hypersensitivity, acute gallbladder disease, hypoglycemia (when used with insulin/sulfonylurea), injection site reactions, and allergic reactions